Order Article Reprints

Tsai M-J, Hung J-Y, Ma J-Y, Tsai Y-C, Wu K-L, Lee M-H, Kuo C-Y, Chuang C-H, Lee T-H, Lee Y-L, et al. Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. Cancers. 2023; 15(7):2019. https://doi.org/10.3390/cancers15072019

Tsai, Ming-Ju, Jen-Yu Hung, Juei-Yang Ma, Yu-Chen Tsai, Kuan-Li Wu, Mei-Hsuan Lee, Chia-Yu Kuo, Cheng-Hao Chuang, Tai-Huang Lee, Yen-Lung Lee, and et al. 2023. "Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib" Cancers 15, no. 7: 2019. https://doi.org/10.3390/cancers15072019

Tsai, M.-J., Hung, J.-Y., Ma, J.-Y., Tsai, Y.-C., Wu, K.-L., Lee, M.-H., Kuo, C.-Y., Chuang, C.-H., Lee, T.-H., Lee, Y.-L., Huang, C.-M., Shen, M.-C., Yang, C.-J., & Chong, I.-W. (2023). Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. Cancers, 15(7), 2019. https://doi.org/10.3390/cancers15072019